Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases : An autoradiography study using [125I]α-conotoxinMII in the striatum and thalamus

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Experimental Neurology

• Publication date

  2005-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.EXPNEUROL.2004.10.004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

  2006cited by this paper
• Dementia with Lewy bodies

  2004cited by this paper
• Nicotinic Acetylcholine Receptor Distribution in Alzheimer's Disease, Dementia with Lewy Bodies, Parkinson's Disease, and Vascular Dementia: In Vitro Binding Study Using 5-[125I]-A-85380

  2004cited by this paper
• Loss of α‐conotoxinMII‐ and A85380‐sensitive nicotinic receptors in Parkinson's disease striatum

  2004cited by this paper
• Introduction

  2003cited by this paper
• Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice

  2003cited by this paper
• Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice.

  2003cited by this paper
• Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression.

  2002cited by this paper
• 5‐Iodo‐A‐85380 binds to α‐conotoxin MII‐sensitive nicotinic acetylcholine receptors (nAChRs) as well as α4β2* subtypes

  2002cited by this paper
• Distribution and Pharmacology of α6-Containing Nicotinic Acetylcholine Receptors Analyzed with Mutant Mice

  2002cited by this paper
• Cellular and synaptic mechanisms of nicotine addiction.

  2002cited by this paper
• Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites.

  2002cited by this paper
• Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease.

  2002cited by this paper
• Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models

  2001cited by this paper
• Vulnerability of 125I-α-Conotoxin MII Binding Sites to Nigrostriatal Damage in Monkey

  2001cited by this paper
• Nicotinic receptors at the amino acid level.

  2000cited by this paper
• 125I-α-Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain

  2000cited by this paper
• Human α6 AChR subtypes: subunit composition, assembly, and pharmacological responses

  2000cited by this paper
• Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease.

  2000cited by this paper
• Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.

  2000cited by this paper
• International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.

  1999cited by this paper
• Acetylcholine in mind: a neurotransmitter correlate of consciousness?

  1999cited by this paper
• Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n ortropane as a selective and potent inhibitor of the neuronal dopamine transporter.

  1999cited by this paper
• Functional α6-Containing Nicotinic Receptors Are Present in Chick Retina

  1999cited by this paper
• Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes.

  1999cited by this paper
• Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.

  1999cited by this paper
• Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia

  1999cited by this paper
• Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine.

  1998cited by this paper
• Dementia With Lewy Bodies: Clinical, Pathological, and Treatment Issues

  1998cited by this paper
• Clinical neurochemistry: developments in dementia research based on brain bank material

  1998cited by this paper
• Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.

  1998cited by this paper
• Human neuronal nicotinic receptors.

  1997cited by this paper
• Toward an agreement on terminology of nuclear and subnuclear divisions of the motor thalamus.

  1997cited by this paper
• [125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors.

  1997cited by this paper
• The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies

  1997cited by this paper
• Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I]α-bungarotoxin binding

  1997cited by this paper
• Multiarchitectonic and stereotactic atlas of the human thalamus

  1997cited by this paper
• The primate motor thalamus.

  1996cited by this paper
• A New -Conotoxin Which Targets 32 Nicotinic Acetylcholine Receptors (*)

  1996cited by this paper
• Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.

  1995cited by this paper
• Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons.

  1995cited by this paper
• Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions.

  1995cited by this paper
• Molecular evolution of the nicotinic acetylcholine receptor: An example of multigene family in excitable cells

  1995cited by this paper
• The specificity of the 'nonspecific' midline and intralaminar thalamic nuclei.

  1994cited by this paper
• Distribution of Nicotinic Receptors in the Human Hippocampus and Thalamus

  1994cited by this paper
• Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat.

  1992cited by this paper
• Patterns of termination of cerebellar and basal ganglia efferents in the rat thalamus. Strictly segregated and partly overlapping projections.

  1992cited by this paper
• Parkinson's disease: pathophysiology

  1991cited by this paper
• Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): Clinical, neuropsychological, and neuropathological components

  1990cited by this paper
• Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

  1990cited by this paper
• Organization of central cholinergic systems.

  1989cited by this paper
• Distribution of tachykinin- and enkephalin-immunoreactive fibers in the human thalamus.

  1989cited by this paper
• Diffuse Lewy body disease and progressive dementia

  1988cited by this paper
• Distribution of cerebellar terminations and their relation to other afferent terminations in the ventral lateral thalamic region of the monkey.

  1983cited by this paper
• Parkinsonism

  1967cited by this paper

• Nicotinic acetylcholine receptor subtype expression, function, and pharmacology: Therapeutic potential of α-conotoxins.

  2023cites this paper
• Nicotinic acetylcholine receptors in neurological and psychiatric diseases.

  2023cites this paper
• Synaptic determinants of cholinergic interneurons hyperactivity during parkinsonism

  2022cites this paper
• Striatal cholinergic transmission. Focus on nicotinic receptors’ influence in striatal circuits

  2021cites this paper
• Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine

  2020cites this paper
• Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson's Disease Models.

  2019cites this paper
• Nicotinic acetylcholine receptors in experimental models of Parkinson’s disease and levodopa-induced dyskinesia : focus on α5 subunit-containing receptors

  2019cites this paper
• Visual hallucinations, thalamocortical physiology and Lewy Body Disease: A Review.

  2019cites this paper
• A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia.

  2018cites this paper
• Assessment of the visual thalamic circuitry in hallucinations in dementia with Lewy bodies

  2017cites this paper
• Cholinergic pathology in dementia with Lewy bodies

  2017cites this paper
• Nicotinic Receptors

  2014cites this paper
• Molecular imaging biomarkers for dementia with Lewy bodies: an update

  2014cites this paper
• Striatal cholinergic interneuron regulation and circuit effects

  2014cites this paper
• Nicotinic Acetylcholine Receptors in Alzheimer’s and Parkinson’s Disease

  2014cites this paper
• Positional Scanning Mutagenesis of α-Conotoxin PeIA Identifies Critical Residues That Confer Potency and Selectivity for α6/α3β2β3 and α3β2 Nicotinic Acetylcholine Receptors*

  2013cites this paper
• Positional-scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectively for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors

  2013cites this paper
• Role of alpha6 nicotinic receptors in CNS dopaminergic function; relevance to addiction and neurological disorders

  2012cites this paper
• Targeting nicotinic receptors for Parkinson's disease therapy.

  2011cites this paper
• α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease

  2011cites this paper
• Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson ’ s Disease

  2011cites this paper
• Localisation of pre- and postsynaptic cholinergic markers in the human brain.

  2011cites this paper
• Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.

  2011cites this paper
• Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models

  2011cites this paper
• Nicotinic Receptors in Brain Diseases

  2011cites this paper
• α‐Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between 06 β4 and 0:6 β2 nicotinic acetylcholine receptors and blocks nicotine‐stimulated norepinephrine release

  2010cites this paper
• α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.

  2010cites this paper
• Synthesis and analgesic activity of new pyridine-based heterocyclic derivatives

  2010cites this paper
• Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders

  2010cites this paper
• Käärmeistä ja merietanoista eristettyjen toksiinien farmakologiset ja terapeuttiset vaikutukset neuronaalisiin nikotiinireseptoreihin

  2010cites this paper
• Nicotinic Receptor Mechanisms in Neuropsychiatric Disorders: Therapeutic Implications

  2010cites this paper
• Decrease of Nicotinic Receptors in the Nigrostriatal System in Parkinson's Disease

  2009cites this paper
• Mysterious α6-containing nAChRs: function, pharmacology, and pathophysiology

  2009cites this paper
• Nicotine and Parkinson's disease: Implications for therapy

  2008cites this paper
• Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission

  2008cites this paper
• Cerebral amyloid angiopathy in Lewy body disease

  2008cites this paper
• Nigrostriatal Damage Preferentially Decreases a Subpopulation of α6β2* nAChRs in Mouse, Monkey, and Parkinson's Disease Striatum

  2007cites this paper
• Nigrostriatal Damage Preferentially Decreases a Subpopulation of (cid:1) 6 (cid:2) 2* nAChRs in Mouse, Monkey, and Parkinson’s Disease Striatum

  2007cites this paper
• Nicotinic receptors as CNS targets for Parkinson's disease.

  2007cites this paper
• Heterogeneity and complexity of native brain nicotinic receptors.

  2007cites this paper
• Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development.

  2007cites this paper
• Muscarinic Receptors in the Thalamus in Progressive Supranuclear Palsy and Other Neurodegenerative Disorders

  2007cites this paper
• Ion Channels – Ligand Gated

  2007cites this paper
• Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson's Disease Therapy

  2006cites this paper
• Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.

  2006cites this paper
• Epibatidine analogues as selective ligands for the αxβ2-containing subtypes of nicotinic acetylcholine receptors

  2005cites this paper
• Neuroscience and Biobehavioral Reviews

  year unknowncites this paper